A purple and pink letter v on a white background.
September 18, 2018

How Social Media Is Altering Marketing for Medical Aesthetics

Social media has become a vital way for people to connect and communicate. As consumers spend more time on social networks, they are beginning to have much more profound effects on our behaviors and attitudes, which alters the marketing landscape for business utilizing these platforms in their regular strategies. In fact, social media now plays a pivotal role in presenting medical aesthetics as a feasible option for consumers active on the platforms.

As a provider, it is imperative that you understand how social sites play into clients’ daily decision-making and how to streamline your marketing strategy to harness the power of these platforms for your business.

A Short Social Media History Lesson

The first social media website—SixDegrees.com—was created in 1997. Based on the theory that all people are linked to each other, even strangers, by six connections of friends to friends or fewer, the platform allowed users to create a friend matrix, send messages, post bulletin board items, and see how they were connected to others on the site. It wasn’t until 2004 that Facebook, the historically most popular social network to date, was launched. Since then, the social media market has grown rapidly.

With this proliferation of social sites, consumer use has grown exponentially. To start, the rate of United States-based adults using social media has shot up from 5% in 2005 to 69% today, with that figure rising as high as to 88% for 18 to 29-year-olds, according to the Pew Research Center. User growth and usage varies by platform, but our habits are mostly the same across platforms. For all social networks, a study on Americans’ digital habits found that in 2017, 35% of users posted on social networking sites daily, spending an average 23.6 hours online each week.  

It’s hard to believe that in just 14 years, social media is now so integral to our lives that “selfie,” a term formed to describe taking a picture of oneself for social media, is listed in most academic dictionaries and there has become a product market to improve our selfies, from apps to selfie sticks.

The bottom line: These platforms have transformed the way we communicate, interact, and even view ourselves. And this is very much apparent in the medical aesthetics space.

Social Media and the Popularity of Medical Aesthetics

While patients’ individual aesthetic choices are certainly influenced by many factors, including age, relationship status, income, and more, social media is becoming uniquely powerful in shaping personal perceptions of beauty and motivating aesthetic purchasing decisions.

As mentioned, the proliferation of the selfie is commonplace on social media, but it’s also a driving force for the adoption of aesthetic treatments. The desire to look good in one’s own social media images is a well-reported key factor fueling demand for aesthetic services today. With professionals reporting that younger patients up to those in middle age increasingly form impressions of their own appearance through their social media accounts, it’s clear that social media is an area in which consumers are more accepting of your insight. In fact, 55% of facial plastic surgeons said patients in their practice reported that they were motivated by a desire to look better in selfies in 2017, up from 13% in 2016. Another survey by review site, RealSelf , found that almost half of all patients reported social media as an influential factor when considering or opting for a cosmetic procedure.

Researchers have theorized that social sites have a greater impact than mass media and advertising on consumers because they incorporate a sense of authenticity, personalization, and day-to-day life that makes the content and images feel more immediate and relevant. Likewise, with celebrities and beauty influencers alike being more open about their aesthetic treatments via social media, many users are beginning to adopt a more positive view of these procedures at an even younger age . These factors, combined with the desire to look good online makes this marketing space ripe for your business.

So, with consumers on social media becoming ever more receptive to aesthetic treatments, it would be a major miss for aesthetic practitioners focusing on patient acquisition not to tap into these markets—or to do so but with an ineffective strategy rife with marketing mistakes.

Looking to get started with a strong social media marketing strategy for your medical aesthetics business? Download our latest report, “Going Social: How Social Media Is Altering the Marketing Landscape for Medical Aesthetics,” for six essential tips to strategize and define a clear marketing plan for a better business outcome.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.